Preface |
|
xi | |
Acknowledgments |
|
xiii | |
About the Editors |
|
xv | |
Contributors |
|
xvii | |
Section 1 Anxiety Disorders |
|
|
1 Cognitive Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder |
|
|
3 | (6) |
|
|
|
2 Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placebo in Generalized Social Phobia |
|
|
9 | (10) |
|
|
Section 2 Bipolar Disorder |
|
|
3 Lithium Plus Valproate Combination versus Monotherapy for Relapse Prevention in Bipolar I Disorder (BALANCE) |
|
|
19 | (5) |
|
|
|
4 Mood Stabilizer Monotherapy versus Adjunctive Antidepressant for Bipolar Depression: The STEP-BD Trial |
|
|
24 | (6) |
|
|
|
5 Suicide Risk in Bipolar Disorder: Comparing Lithium, Divalproex, and Carbamazepine |
|
|
30 | (5) |
|
|
|
6 The Long-Term Natural History of Bipolar I Disorder |
|
|
35 | (8) |
|
|
Section 3 Child and Adolescent Disorders |
|
|
7 The Multimodal Treatment Study of Children with Attention Deficit/Hyperactivity Disorder (MTA) |
|
|
43 | (7) |
|
|
8 Adolescents with SSRI-Resistant Depression: The TORDIA Trial |
|
|
50 | (5) |
|
|
|
9 Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study |
|
|
55 | (6) |
|
|
|
10 Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety: CAMS |
|
|
61 | (6) |
|
|
|
|
11 Predictors of Suicidal Events: The Treatment of Adolescent Suicide Attempters (TASA) Study |
|
|
67 | (6) |
|
|
|
12 Cognitive Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents with OCD |
|
|
73 | (6) |
|
|
|
13 Initial Treatment of Bipolar I Disorder in Children and Adolescents: The TEAM Trial |
|
|
79 | (5) |
|
|
|
14 The Treatment for Adolescents with Depression Study (TADS) |
|
|
84 | (9) |
|
|
Section 4 Cognitive Disorders: Delirium/Dementia |
|
|
15 Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease: CATIE-AD |
|
|
93 | (7) |
|
|
|
16 Risk of Death with Atypical Antipsychotic Medications for Dementia |
|
|
100 | (6) |
|
|
|
17 Treatment of Delirium in Hospitalized AIDS Patients: A Double-Blind Trial of Haloperidol, Chlorpromazine, and Lorazepam |
|
|
106 | (6) |
|
|
|
18 Memantine in Patients with Moderate to Severe Alzheimer's Disease Already Receiving Donepezil |
|
|
112 | (9) |
|
|
Section 5 Epidemiology |
|
|
19 Global Burden of Mental and Substance Use Disorders |
|
|
121 | (6) |
|
|
|
20 Prevalence and Severity of Psychiatric Comorbidities: The National Comorbidity Survey Replication (NCS-R) |
|
|
127 | (8) |
|
|
Section 6 Insomnia |
|
|
21 Behavioral and/or Pharmacotherapy for Older Patients with Insomnia |
|
|
135 | (8) |
|
|
Section 7 Major Depressive Disorder |
|
|
22 Treatment of Depression in Patients with Alcohol or Drug Dependence: A Meta-Analysis |
|
|
143 | (6) |
|
|
Gustavo A. Angarita Africano |
|
|
23 Suicidality in Pediatric Patients Treated with Antidepressant Drugs: FDA Meta-Analysis |
|
|
149 | (6) |
|
|
|
24 National Institute of Mental Health (NIMH) Treatment of Depression Collaborative Research Program |
|
|
155 | (6) |
|
|
|
25 Efficacy and Safety of Electroconvulsive Therapy in Depressive Disorders: A Systematic Review and Meta-Analysis |
|
|
161 | (6) |
|
|
|
26 Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration |
|
|
167 | (6) |
|
|
|
27 Sequenced Treatment Alternatives to Relieve Depression: STARD |
|
|
173 | (6) |
|
|
|
28 Cognitive Therapy versus Medication in the Treatment of Moderate to Severe Depression |
|
|
179 | (8) |
|
|
Section 8 Obsessive-Compulsive Disorder |
|
|
29 Exposure and Ritual Prevention, Clomipramine, or Their Combination for Obsessive-Compulsive Disorder |
|
|
187 | (5) |
|
|
|
30 Meta-Analysis of the Dose-Response Relationship of SSRIs in Adult Patients with Obsessive-Compulsive Disorder |
|
|
192 | (9) |
|
|
Section 9 Personality Disorders |
|
|
31 Psychotherapy for Borderline Personality Disorder: A Multiwave Study |
|
|
201 | (6) |
|
|
|
|
32 Dialectical Behavior Therapy versus Community Treatment by Experts for Reducing Suicidal Behaviors among Patients with Borderline Personality Disorder |
|
|
207 | (6) |
|
|
|
|
33 Ten-Year Course of Borderline Personality Disorder: The Collaborative Longitudinal Personality Disorders Study |
|
|
213 | (8) |
|
|
|
Section 10 Psychiatry in Primary Care |
|
|
34 Depressive Symptoms and Health-Related Quality of Life: The Heart and Soul Study |
|
|
221 | (5) |
|
|
|
35 The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial |
|
|
226 | (7) |
|
|
Section 11 Women's Mental Health |
|
|
36 Buprenorphine versus Methadone During Pregnancy: The MOTHER Trial |
|
|
233 | (8) |
|
|
Section 12 Schizophrenia |
|
|
37 QTc-Interval Abnormalities and Psychotropic Drug Therapy in Psychiatric Patients |
|
|
241 | (6) |
|
|
|
38 Tardive Dyskinesia with Atypical versus Conventional Antipsychotic Medications |
|
|
247 | (6) |
|
|
|
39 Effectiveness of Antipsychotics in the Treatment of Schizophrenia: CATIE Phase 1 |
|
|
253 | (7) |
|
|
|
40 Clozapine for Treatment-Resistant Schizophrenia |
|
|
260 | (6) |
|
|
|
41 Effectiveness of Clozapine versus Other Atypical Antipsychotics: Clinical Antipsychotic Trials for Interventions Effectiveness (CATIE) |
|
|
266 | (8) |
|
|
|
42 Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death |
|
|
274 | (5) |
|
|
|
43 Switching Antipsychotics to Reduce Metabolic Risk: The CAMP Trial |
|
|
279 | (6) |
|
|
|
44 Cost Utility of Atypical Antipsychotics: CUtLASS-1 |
|
|
285 | (5) |
|
|
|
45 North American Prodrome Longitudinal Study |
|
|
290 | (5) |
|
|
|
46 Clozapine for Suicidality in Schizophrenia: The International Suicide Prevention Trial (InterSePT) |
|
|
295 | (5) |
|
|
|
47 A Cohort Study of Oral and Depot Antipsychotics after First Hospitalization for Schizophrenia |
|
|
300 | (9) |
|
|
Section 13 Substance Use Disorders |
|
|
48 Methadone Maintenance versus Detoxification and Psychosocial Treatment for Opioid Dependence: The M180 Study |
|
|
309 | (5) |
|
|
|
49 Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study |
|
|
314 | (7) |
|
|
|
50 Levomethadyl Acetate versus Buprenorphine versus Methadone for Opioid Dependence |
|
|
321 | (6) |
|
|
Index |
|
327 | |